Friday, October 12, 2012

• Isis Pharma Owns 18% of RegulusZacks (Fri, Oct 12)

Wednesday, October 10, 2012

• Gevo, Alnylam, Megaupload, Google: Intellectual Propertyat Bloomberg (Wed, Oct 10)

Friday, October 5, 2012

• Alnylam-ISIS Venture Prices IPOZacks (Fri, Oct 5)

Wednesday, October 3, 2012

• Don't Judge Monsanto By A Slow Quarterat Seeking Alpha (Wed, Oct 3)

Wednesday, September 26, 2012

• The Latest Skirmish in the Patent Warsat Motley Fool (Wed, Sep 26)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Other EventsEDGAR Online (Wed, Sep 26)

Tuesday, September 25, 2012

• Court rules in favor of Alnylamat theflyonthewall.com (Tue, Sep 25)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Tue, Sep 25)

Thursday, September 20, 2012

• Alnylam Pharmaceuticals' Management Presents at UBS 2012 Global Life Sciences Conference (Transcript)at Seeking Alpha (Thu, Sep 20)

Wednesday, September 19, 2012

• Healthcare Stocks, Including Taro Pharmaceutical, Making Big Moves on September 19, 2012at Investopedia (Wed, Sep 19)
• Alnylam downgraded to Neutral from Overweight at Piper Jaffraytheflyonthewall.com (Wed, Sep 19)

Wednesday, September 12, 2012

• Alnylam Pharmaceuticals' CEO Presents at Morgan Stanley Global Healthcare Conference (Transcript)at Seeking Alpha (Wed, Sep 12)

Monday, September 10, 2012

• Biotech: On The Way To Meeting Highly Ambitious Expectationsat Seeking Alpha (Mon, Sep 10)

Thursday, September 6, 2012

• Alnylam Presents Data on ALN-RSV01Zacks (Thu, Sep 6)

Sunday, September 2, 2012

• Monsanto, Alnylam To Apply Genomics To Agricultural Pestsat Seeking Alpha (Sun, Sep 2)

Thursday, August 30, 2012

• The Zacks Analyst Blog Highlights: Alnylam Pharmaceuticals, Monsanto, Novartis, Biogen and Cubist PharmaceuticalsZacks (Thu, Aug 30)

Wednesday, August 29, 2012

• Alnylam & Monsanto CollaborateZacks (Wed, Aug 29)
• A Biotech Field of Dreams?at Motley Fool (Wed, Aug 29)

Tuesday, August 28, 2012

• Alnylam and Monsanto form biopesticide partnershipAP (Tue, Aug 28)
• Pharmacyclics Among Healthcare's Biggest Movers on August 28, 2012at Investopedia (Tue, Aug 28)
• Monsanto pays biotech firm Alnylam $29 million for IP rightsat bizjournals.com (Tue, Aug 28)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Tue, Aug 28)
• Alnylam, Monsanto form strategic alliancetheflyonthewall.com (Tue, Aug 28)

Monday, August 27, 2012

• Alnylam and Monsanto sign agricultural biotech dealat bizjournals.com (Mon, Aug 27)

Thursday, August 23, 2012

• Healthcare Business Recap: Vivus Director BUYS Its Shares, Humana’s New INITIATIVEat Wall St. Cheat Sheet (Thu, Aug 23)

Add ALNY News to My Yahoo!